Document is current
Any future updates will be listed below
-
Authors
Ehms, Blanca
Kaemmerer, Daniel
Sänger, Jörg
Schulz, Stefan
Lupp, Amelie http://orcid.org/0000-0003-0141-7310
-
Funding
Funding for this research was provided by:
Friedrich-Schiller-Universität Jena
- License Information
-
More Information
Article History
Received: 24 June 2022
Accepted: 23 August 2022
First Online: 30 August 2022
Competing interests
: Daniel Kaemmerer received support for travelling to meetings by the companies IPSEN and PFIZER. Stefan Schulz is the founder and scientific advisor of 7TM Antibodies GmbH, Jena, Germany, and declares no competing non-financial interests but competing financial interests. All other authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
